“…Many immunohistochemical studies have demonstrated absent or decreased expression of syndecan-1 in many kinds of carcinomas with more aggressive characteristics (Fujiya et al, 2001;Inki et al, 1994;Kumar-Singh et al, 1998;Matsumoto et al, 1997;Stanley et al, 1999;Toyoshima et al, 2001;Wiksten et al, 2000;Wiksten et al, 2001). There are several reports on syndecan-1 expression in head and neck carcinoma (Anttonen et al, 1999;Inki et al, 1994;Kurokawa et al, 2003;Kurokawa et al, 2006;Muramatsu et al, 2008;Ro et al, 2006). However, head and neck carcinoma includes oral, nasal, laryngeal and esophageal carcinomas, and investigation of syndecan-1 expression in oral cancer has been limited.…”